| Year |
Citation |
Score |
| 2023 |
Malta TM, Sabedot TS, Morosini NS, Datta I, Garofano L, Vallentgoed WR, Varn FS, Aldape K, D'Angelo F, Bakas S, Barnholtz-Sloan JS, Gan HK, Hasanain M, Hau AC, Johnson KC, ... ... Poisson LM, et al. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Research. PMID 38117484 DOI: 10.1158/0008-5472.CAN-23-2093 |
0.303 |
|
| 2020 |
Darvishi P, Batchala PP, Patrie JT, Poisson LM, Lopes MB, Jain R, Fadul CE, Schiff D, Patel SH. Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes. Ajnr. American Journal of Neuroradiology. PMID 32327434 DOI: 10.3174/Ajnr.A6511 |
0.313 |
|
| 2020 |
Wells M, Asmaro KP, Sabedot TS, Mosella MS, Malta, PharmD TM, Nelson K, Snyder J, deCarvalho A, Mukherjee A, Chitale D, Robin A, Rosenblum ML, Mikkelsen T, Poisson L, et al. OR32-03 Serum Cell-Free Methylation-Based Signatures Distinguishes Pituitary Tumors According to Functional Status and from Other Neoplasia: A Liquid Biopsy Approach Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.542 |
0.365 |
|
| 2020 |
Sabedot T, Malta T, Snyder J, Nelson K, Wells M, deCarvalho A, Mukherjee A, Chitale D, Mosella M, Asmaro K, Robin A, Rosenblum M, Mikkelsen T, Rock J, Poisson L, et al. Abstract A10: Glioma cell-free DNA methylation marker for diagnosis and monitoring Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-A10 |
0.374 |
|
| 2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Poisson LM, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.354 |
|
| 2019 |
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology. PMID 31158293 DOI: 10.1093/Neuonc/Noz061 |
0.306 |
|
| 2019 |
Wu CC, Jain R, Neto L, Patel S, Poisson LM, Serrano J, Ng V, Patel SH, Placantonakis DG, Zagzag D, Golfinos J, Chi AS, Snuderl M. MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas. Neuroradiology. PMID 31134296 DOI: 10.1007/S00234-019-02219-8 |
0.302 |
|
| 2019 |
Snyder J, Poisson LM, Noushmehr H, Castro AV, de Carvalho AC, Robin A, Mukherjee A, Lee I, Walbert T. Clinical and research applications of a brain tumor tissue bank in the age of precision medicine. Personalized Medicine. PMID 30816054 DOI: 10.2217/Pme-2018-0102 |
0.348 |
|
| 2019 |
Noushmehr H, Sabedot TS, Malta TM, Nelson KK, Snyder J, Wells M, Mosella MS, deCarvalho AC, Asmaro K, Scarpace L, Robin AM, Rosenblum ML, Mikkelsen T, Rock J, Walbert T, ... ... Poisson LM, et al. Abstract LB-234: Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-234 |
0.389 |
|
| 2019 |
Wells M, Sabedot T, Malta T, Snyder J, Poisson L, Noushmehr H. Abstract 1640: Deep learning classification of neuro-oncology medical documents Cancer Research. 79: 1640-1640. DOI: 10.1158/1538-7445.Am2019-1640 |
0.311 |
|
| 2019 |
Lee IY, Sabedot T, Malta T, Snyder J, Wells M, DeCarvalho A, Mukherjee A, Chitale D, Asmaro KP, Robin AM, Rosenblum ML, Mikkelsen T, Rock JP, Poisson L, Walbert T, et al. Detection of Glioma and Prognostic Subtypes by Noninvasive Circulating Cell-Free DNA Methylation Markers Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_630 |
0.381 |
|
| 2019 |
Asmaro KP, Mosella MS, Wells M, Sabedot T, Malta T, Nelson K, Snyder J, DeCarvalho A, Mukherjee A, Chitale D, Aho T, Robin AM, Rosenblum ML, Mikkelsen T, Poisson L, et al. Candidate Regulatory Elements in Coding and Noncoding Regions are Associated With Invasive Behavior in Pituitary Tumors Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_157 |
0.359 |
|
| 2019 |
Mureb M, Jain R, Poisson L, Aguiar Littig I, Nunes Neto L, Wu C, Ng V, Patel S, Patel S, Serrano J, Kurz S, Cahill D, Bendszus M, von Deimling A, Placantonakis D, et al. NIMG-09. NONINVASIVE PERFUSION IMAGING BIOMARKER OF MALIGNANT GENOTYPE IN ISOCITRATE DEHYDROGENASE MUTANT GLIOMAS Neuro-Oncology. 21: vi163-vi163. DOI: 10.1093/Neuonc/Noz175.681 |
0.312 |
|
| 2019 |
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, deCarvalho A. GENE-55. GENE EXPRESSION SIGNATURE ASSOCIATED WITH AGGRESSIVE GLIOBLASTOMA GROWTH IS ENRICHED IN CHROMATIN MODIFICATION AND STEMNESS TRANSCRIPTIONAL REGULATION PROGRAMS Neuro-Oncology. 21: vi109-vi109. DOI: 10.1093/Neuonc/Noz175.457 |
0.388 |
|
| 2019 |
Poisson L, Kouwenhoven MCM, Snyder J, Alfaro-Munoz K, Kaur M, Bates A, Verhaak R, Watts C, Zadeh G, Ryan Ormond D, Claus E, Khasraw M. EPID-23. PURSUIT OF AN INTERNATIONAL LANGUAGE OF GLIOMA RESEARCH: COMMON DATA ELEMENTS FOR THE LONGITUDINAL STUDY OF ADULT MALIGNANT GLIOMA Neuro-Oncology. 21: vi79-vi79. DOI: 10.1093/Neuonc/Noz175.323 |
0.314 |
|
| 2018 |
Wu CC, Jain R, Radmanesh A, Poisson LM, Guo WY, Zagzag D, Snuderl M, Placantonakis DG, Golfinos J, Chi AS. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas. Ajnr. American Journal of Neuroradiology. PMID 30190259 DOI: 10.3174/Ajnr.A5794 |
0.307 |
|
| 2018 |
deCarvalho AC, Kim H, Poisson LM, Winn ME, Mueller C, Cherba D, Koeman J, Seth S, Protopopov A, Felicella M, Zheng S, Multani A, Jiang Y, Zhang J, Nam DH, et al. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma. Nature Genetics. PMID 29686388 DOI: 10.1038/S41588-018-0105-0 |
0.339 |
|
| 2018 |
de Souza CF, Sabedot TS, Malta TM, Stetson L, Morozova O, Sokolov A, Laird PW, Wiznerowicz M, Iavarone A, Snyder J, deCarvalho A, Sanborn Z, McDonald KL, Friedman WA, Tirapelli D, ... Poisson L, et al. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence. Cell Reports. 23: 637-651. PMID 29642018 DOI: 10.1016/J.Celrep.2018.03.107 |
0.387 |
|
| 2018 |
Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 173: 400-416.e11. PMID 29625055 DOI: 10.1016/J.Cell.2018.02.052 |
0.329 |
|
| 2018 |
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwińska P, Mazurek S, Mishra L, Heyn H, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 173: 338-354.e15. PMID 29625051 DOI: 10.1016/J.Cell.2018.03.034 |
0.355 |
|
| 2018 |
Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Poisson LM, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020 |
0.363 |
|
| 2018 |
Liu J, Lichtenberg T, Hoadley K, Cherniack A, Poisson L, Kovatich A, Benz C, Thorsson V, Shriver C, Hu H. Abstract P3-16-01: Using the new pan-cancer clinical data resource (TCGA-CDR) to identify breast cancer genomic correlates associating with different survival outcome endpoints Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-16-01 |
0.339 |
|
| 2018 |
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein J, Kamińska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwińska P, Mazurek S, Mishra L, Heyn H, et al. Abstract LB-373: Comprehensive analysis of cancer stemness Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-373 |
0.365 |
|
| 2018 |
Berezovsky AD, Transou AD, Irtenkauf SM, Hasselbach LA, Koeman J, Kim H, Verhaak RG, Mikkelsen T, Poisson LM, deCarvalho AC. Abstract 3491: Heterogeneous extrachromosomal amplification of mutant PDGFRA is associated with an aggressive phenotype in glioblastoma Cancer Research. 78: 3491-3491. DOI: 10.1158/1538-7445.Am2018-3491 |
0.336 |
|
| 2018 |
Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Hu H. Abstract 3287: An integrated TCGA pan-cancer clinical data resource to drive high quality survival outcome analytics Cancer Research. 78: 3287-3287. DOI: 10.1158/1538-7445.Am2018-3287 |
0.363 |
|
| 2018 |
Sabedot T, deCarvalho A, Poisson L, Snyder J, Walbert T, Lee I, Kalkanis S, Berman B, Noushmehr H. GENE-13. GENOMIC FUNCTIONAL ENHANCERS DEFINE POTENTIAL TUMORIGENESIS OF G-CIMP-LOW (IDH-MUTANT ASTROCYTOMA) TUMORS INDEPENDENT OF PROMOTER METHYLATION Neuro-Oncology. 20: vi105-vi105. DOI: 10.1093/Neuonc/Noy148.439 |
0.34 |
|
| 2018 |
Mosella M, Malta T, Sabedot T, Felicella M, Aho T, Poisson L, deCarvalho A, Snyder J, Lee I, Kalkanis S, Walbert T, Noushmehr H, Rock J, Castro AV. GENE-07. GENOMIC ENHANCER METHYLATION IS ASSOCIATED WITH BIOLOGICAL AND CLINICAL FEATURES IN PITUITARY TUMORS Neuro-Oncology. 20: vi104-vi104. DOI: 10.1093/Neuonc/Noy148.434 |
0.351 |
|
| 2017 |
Patel SH, Poisson LM, Brat DJ, Zhou Y, Cooper L, Snuderl M, Thomas C, Franceschi AM, Griffith B, Flanders A, Golfinos JG, Chi AS, Jain R. T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower Grade Gliomas: A TCGA/TCIA Project. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28751449 DOI: 10.1158/1078-0432.Ccr-17-0560 |
0.353 |
|
| 2017 |
Brodie S, Kyung Lee H, Jiang W, Cazacu S, Xiang C, Poisson LM, Datta I, Kalkanis S, Ginsberg D, Brodie C. The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells. Oncotarget. PMID 28423669 DOI: 10.18632/Oncotarget.15991 |
0.354 |
|
| 2016 |
Jiang W, Finniss S, Cazacu S, Xiang C, Brodie Z, Mikkelsen T, Poisson L, Shackelford DB, Brodie C. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma. Oncotarget. PMID 27486821 DOI: 10.18632/Oncotarget.10919 |
0.331 |
|
| 2016 |
Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, ... ... Poisson L, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 164: 550-563. PMID 26824661 DOI: 10.1016/J.Cell.2015.12.028 |
0.373 |
|
| 2016 |
Poisson LM, Mikkelsen T, deCarvalho AC. Abstract A08: Neurosphere culture captures the clinical and molecular diversity of glioblastoma tumors Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-A08 |
0.417 |
|
| 2016 |
Stetson LC, Souza CFd, Malta TM, Sabedot TS, Ostrom Q, Liao P, Tirapelli DPdC, Neder L, Carlotti CG, Akbani R, Salama S, Poisson L, Brat D, Noushmehr H, Barnholtz-Sloan J. Abstract 780: Multi-omic profiling of gliomas reveals distinct DNA methylation changes at tumor recurrence Cancer Research. 76: 780-780. DOI: 10.1158/1538-7445.Am2016-780 |
0.41 |
|
| 2016 |
Munkarah A, Poisson L, Kim S, Chhina J, Giri S, Rattan R. Abstract 11: Metformin exerts differential metabolic effects in ovarian cancer cell lines Cancer Research. 76: 11-11. DOI: 10.1158/1538-7445.Am2016-11 |
0.306 |
|
| 2015 |
Giladi ND, Ziv-Av A, Lee HK, Finniss S, Cazacu S, Xiang C, Ben-Asher HW, deCarvalho A, Mikkelsen T, Poisson L, Brodie C. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop. Oncotarget. PMID 26267319 DOI: 10.18632/Oncotarget.4205 |
0.363 |
|
| 2015 |
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, ... ... Poisson LM, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121 |
0.517 |
|
| 2015 |
Thomas SL, Schultz CR, Mouzon E, Golembieski WA, Naili RE, Radakrishnan A, Lemke N, Poisson LM, Gutiérrez JA, Cottingham S, Rempel SA. Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival. Brain Pathology (Zurich, Switzerland). 25: 391-400. PMID 24862407 DOI: 10.1111/Bpa.12161 |
0.362 |
|
| 2015 |
Thomas SL, Schultz CR, Mouzon E, Golembieski WA, Lemke N, Poisson LM, Gutierrez JA, Cottingham S, Rempel SA. Abstract 2363: Loss of Sparc in p53-null astrocytes alters collagen deposition and promotes macrophage activation and tumor phagocytosis Cancer Research. 75: 2363-2363. DOI: 10.1158/1538-7445.Am2015-2363 |
0.342 |
|
| 2015 |
Brodie C, Buchris E, Finniss S, Cazacu S, Xiang C, Lee HK, Poisson L. Abstract 2327: Placenta-derived mesenchymal stem cells and their secreted exosomes inhibit the self-renewal and stemness of glioma stem cells in vitro and in vivo Cancer Research. 75: 2327-2327. DOI: 10.1158/1538-7445.Am2015-2327 |
0.325 |
|
| 2015 |
deCarvalho A, Kim H, Poisson L, Mueller C, Cherba D, Winn M, Petricoin E, Verhaak R, Mikkelsen T. GENO-12CLONAL EVOLUTION AND GENOMIC DIVERSITY IN A PANEL GLIOBLASTOMA TUMORS, NEUROSPHERE CULTURES AND ORTHOTOPIC XENOGRAFTS Neuro-Oncology. 17: v93.4-v94. DOI: 10.1093/Neuonc/Nov215.12 |
0.346 |
|
| 2015 |
Souza C, Malta T, Sabedot T, Stetson L, Tirapelli D, Neder L, Carlotti C, ZenKlusen J, Salama S, Poisson L, Brat D, Barnholtz-Sloan J, Noushmehr H. Epig-16Most Differential Dna Methylation Changes Occur At Candidate Enhancer Elements For Recurrent Lower Grade Glioma And Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.16 |
0.33 |
|
| 2015 |
Lee HK, Brodie S, Finnis S, Cazacu S, Xiang C, Xin H, Kalkanis S, Poisson L, Ginsburg D, Brodie C. Cbio-06The Novel E2F1-Regulated Long Non-Coding Rna Talnec2 Is Highly Expressed In Gbm From Short-Term Survivors And Regulates The Migration, Stemness And Radiation Response Of Glioma Stem Cells Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov209.06 |
0.343 |
|
| 2015 |
Madi HM, Al-Wahab Z, Poisson L, Burmeister C, Alford SH, Morris RT, Rattan R, Munkarah AR. Association of AMPK signaling pathway with tumor response to treatment in ovarian cancer Gynecologic Oncology. 137: 178. DOI: 10.1016/J.Ygyno.2015.01.447 |
0.319 |
|
| 2014 |
Mazaris P, Hong X, Altshuler D, Schultz L, Poisson LM, Jain R, Mikkelsen T, Rosenblum M, Kalkanis S. Key determinants of short-term and long-term glioblastoma survival: a 14-year retrospective study of patients from the Hermelin Brain Tumor Center at Henry Ford Hospital. Clinical Neurology and Neurosurgery. 120: 103-12. PMID 24731587 DOI: 10.1016/J.Clineuro.2014.03.001 |
0.333 |
|
| 2014 |
Berezovsky AD, Poisson LM, Cherba D, Webb CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM, Mikkelsen T, deCarvalho AC. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. Neoplasia (New York, N.Y.). 16: 193-206, 206.e19-25. PMID 24726753 DOI: 10.1016/J.Neo.2014.03.006 |
0.358 |
|
| 2014 |
Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J, Freymann J, Jaffe CC, Mikkelsen T, Flanders A. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology. 272: 484-93. PMID 24646147 DOI: 10.1148/Radiol.14131691 |
0.342 |
|
| 2014 |
deCarvalho AC, Arnold K, Mueller C, Petricoin EF, Poisson LM, Mikkelsen T. Abstract 3795: Cabozantinib affects multiple signaling pathways in glioblastoma and is effective in a subset of xenograft tumors Cancer Research. 74: 3795-3795. DOI: 10.1158/1538-7445.Am2014-3795 |
0.38 |
|
| 2014 |
Berezovsky AD, Poisson LM, Hong X, Mikkelsen T, deCarvalho AC. Abstract 3385: Sox2 is necessary for glioblastoma cell plasticity Cancer Research. 74: 3385-3385. DOI: 10.1158/1538-7445.Am2014-3385 |
0.344 |
|
| 2014 |
Mueller C, deCarvalho AC, Mikkelsen T, Poisson L, Calvert V, Borgman A, Cherba DM, Winn ME, Petricoin EF. Abstract 1213: Comparing protein pathway activation mapping portraits between gliobastoma patient-matched primary tumor, xenografts and neurospheres: implications for precision medicine Cancer Research. 74: 1213-1213. DOI: 10.1158/1538-7445.Am2014-1213 |
0.344 |
|
| 2014 |
Robin A, Raghunathan A, Leung D, Burmeister C, Poisson L, Scarpace L, Walbert T, Mikkelsen T, Lee I. Ge-29Expression Subclass Profile In Pseudoprogression And True Progression In Newly Diagnosed Gbm Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.28 |
0.395 |
|
| 2014 |
Lee HK, Buchris E, Finniss S, Cazacu S, Xiang C, Poisson L, Brodie C. Et-33Placenta-Derived Mesenchymal Stem Cells And Their Secreted Exosomes Inhibit The Self-Renewal And Stemness Of Glioma Stem Cells In Vitro And In Vivo Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou255.33 |
0.32 |
|
| 2014 |
Giladi N, Lee HK, Finniss S, Cazacu S, Xiang C, Poisson L, Mikkelsen T, Ziv-Av A, Brodie C. CS-09 * RTVP-1 PROMOTES THE MESENCHYMAL TRANSFORMATION OF GLIOMA STEM CELLS VIA THE CXCR4 AND IL-6 PATHWAYS Neuro-Oncology. 16: v52-v53. DOI: 10.1093/Neuonc/Nou242.9 |
0.348 |
|
| 2014 |
Mikkelsen T, deCarvalho AC, Arnold K, Mueller C, Petricoin EF, Poisson LM, Irtenkauf S, Hasselbach L. CABOZANTINIB IS EFFECTIVE IN A SUBSET OF XENOGRAFT GBM TUMORS AND AFFECTS MULTIPLE SIGNALING PATHWAYS Neuro-Oncology. 16: iii38-iii38. DOI: 10.1093/Neuonc/Nou208.58 |
0.359 |
|
| 2013 |
Lee HK, Bier A, Cazacu S, Finniss S, Xiang C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, Yalon M, Toren A, Rempel SA, Brodie C. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. Plos One. 8: e54652. PMID 23390502 DOI: 10.1371/Journal.Pone.0054652 |
0.311 |
|
| 2013 |
Jain R, Poisson L, Narang J, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Brat DJ, Jaffe C, Mikkelsen T. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 267: 212-20. PMID 23238158 DOI: 10.1148/Radiol.12120846 |
0.317 |
|
| 2013 |
Brodie C, Giladi N, Ziv-Av A, Lee HK, Finniss S, Cazacu S, Xiang C, Poisson L, Slavin S, Mikkelsen T. Effect of RTVP-1 on the mesenchymal transformation of glioma stem cells (GSCs) and their self-renewal and migration. Journal of Clinical Oncology. 31: 2073-2073. DOI: 10.1200/Jco.2013.31.15_Suppl.2073 |
0.381 |
|
| 2012 |
Jain R, Poisson L, Narang J, Scarpace L, Rosenblum ML, Rempel S, Mikkelsen T. Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study. Ajnr. American Journal of Neuroradiology. 33: 1343-8. PMID 22422183 DOI: 10.3174/Ajnr.A2956 |
0.341 |
|
| 2012 |
Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle (Georgetown, Tex.). 11: 489-502. PMID 22274399 DOI: 10.4161/Cc.11.3.18996 |
0.365 |
|
| 2009 |
Patwa TH, Li C, Poisson LM, Kim HY, Pal M, Ghosh D, Simeone DM, Lubman DM. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray. Electrophoresis. 30: 2215-26. PMID 19582723 DOI: 10.1002/Elps.200800857 |
0.308 |
|
| Show low-probability matches. |